MRSN icon

Mersana Therapeutics
MRSN

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$31
12% upside
High target

1 analyst rating

positive
1  neutral
100%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Guggenheim
Guggenheim
Michael Schmitz
14 Nov ‘25 16 days ago
Truist Securities
Truist Securities
Asthika Goonewardene
50% 1-yr MRSN win rate
13 Nov ‘25 17 days ago
BTIG
BTIG
Justin Zelin
13 Nov ‘25 17 days ago